ABSTRACT
The truncated [1+9-76] CCL2 analogue, also known as 7ND, has been described in numerous reports as an anti-inflammatory and anti-fibrotic agent in a wide spectrum of animal models, e.g. models of cardiovascular disease, graft versus host disease and bleomycin-induced pulmonary fibrosis. 7ND has been reported to function as a competitive inhibitor of CCL2 signaling via CCR2 in human in vitro systems. In contrast, the mechanistic basis of 7ND action in animal models has not been previously reported. Here we have studied how 7ND interacts with CCL2 and CCR2 of murine origin. Surprisingly, 7ND was shown to be a weak inhibitor of murine CCL2/CCR2 signaling and displaced murine CCL2 (JE) from the receptor with a K(i)>1 µM. Using surface plasmon resonance, we found that 7ND binds murine CCL2 with a K(d) of 670 nM, which may indicate that 7ND inhibits murine CCL2/CCR2 signaling by a dominant negative mechanism rather than by competitive binding to the CCR2 receptor. In addition we observed that sub-nanomolar levels of 7ND mediate anti-fibrotic effects in CCR2 negative fibroblasts cultured from fibrotic lung of bleomycin-induced mice. Basal levels of extracellular matrix proteins were reduced (collagen type 1 and fibronectin) as well as expression levels of α-smooth muscle actin and CCL2. Our conclusion from these data is that the previously reported effects of 7ND in murine disease models most probably are mediated via mechanisms independent of CCR2.
Subject(s)
Chemokine CCL2/pharmacology , Fibroblasts/drug effects , Fibrosis/chemically induced , Receptors, CCR2/metabolism , Actins/genetics , Actins/metabolism , Animals , Antibiotics, Antineoplastic/toxicity , Bleomycin/toxicity , Cell Line , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Cloning, Molecular , Cricetinae , Female , Gene Expression Regulation/physiology , Humans , Mice , Mice, Inbred C57BL , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, CCR2/genetics , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolismSubject(s)
Probiotics , Colonic Neoplasms/microbiology , Colonic Neoplasms/prevention & control , Diarrhea/microbiology , Diarrhea/prevention & control , Diarrhea/therapy , Evidence-Based Medicine , Humans , Hypersensitivity/microbiology , Hypersensitivity/prevention & control , Intestinal Diseases/microbiology , Intestinal Diseases/prevention & control , Intestinal Diseases/therapy , Intestines/microbiology , Probiotics/adverse effects , Probiotics/therapeutic use , Treatment OutcomeSubject(s)
Dietary Fiber , Irritable Bowel Syndrome , Prebiotics , Bacteria/growth & development , Bacteria/metabolism , Colon/microbiology , Dietary Fiber/administration & dosage , Dietary Fiber/adverse effects , Fermentation , Humans , Intestinal Absorption , Irritable Bowel Syndrome/diet therapy , Irritable Bowel Syndrome/etiology , Irritable Bowel Syndrome/microbiology , Prebiotics/adverse effectsABSTRACT
The nuclear receptor heterodimers of liver X receptor (LXR) and retinoid X receptor (RXR) are key transcriptional regulators of genes involved in lipid homeostasis and inflammation. We report the crystal structure of the ligand-binding domains (LBDs) of LXRalpha and RXRbeta complexed to the synthetic LXR agonist T-0901317 and the RXR agonist methoprene acid (Protein Data Base entry 1UHL). Both LBDs are in agonist conformation with GRIP-1 peptides bound at the coactivator binding sites. T-0901317 occupies the center of the LXR ligand-binding pocket and its hydroxyl head group interacts with H421 and W443, residues identified by mutational analysis as critical for ligand-induced transcriptional activation by T-0901317 and various endogenous oxysterols. The topography of the pocket suggests a common anchoring of these oxysterols via their 22-, 24- or 27-hydroxyl group to H421 and W443. Polyunsaturated fatty acids act as LXR antagonists and an E267A mutation was found to enhance their transcriptional inhibition. The present structure provides a powerful tool for the design of novel modulators that can be used to characterize further the physiological functions of the LXR-RXR heterodimer.